A new study published in the International Wound Journal highlights a striking parallel: the three-year recurrence rates for diabetic foot ulcers (DFU) and reintervention for chronic limb-threatening ischemia (CLTI) are comparable to—or exceed—those of advanced-stage cancers, including colorectal, breast, prostate, and even lung cancer.
Chongqing, Los Angeles — A landmark global study published today in Research (DOI: 10.34133/research.0702) projects a 220% increase in peripheral artery disease (PAD) cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to more than 360 million.
A recent study reveals that diabetic foot ulcer (DFU) patients transitioning from Medicaid to commercial insurance face a 27% lower risk of major amputation. Conducted by leading experts from ALPS and published in Diabetology, the research highlights the critical role of insurance in improving health outcomes for vulnerable populations. Discover how insurance transitions can help reduce amputation rates for those with DFUs.
A new meta-analysis suggests that reamputation rates following a primary amputation in people with diabetes remain unchanged over the course of two...
In a large prospective study out of Australia involving over 4,700 patients with diabetic foot ulcers (DFUs), researchers identified seven factors...